2D-Health project to investigate next generation medtech with graphene

The £5.2m EPSRC grant will fund a project to explore how two-dimensional materials can improve major health challenges, such as cancer, diabetes and dementia.

The announcement was made today by Jo Johnson, minister of state for universities and science, as part of £17.7m for new healthcare technologies research to address the health issues of an aging UK population.

According to the University, potential areas of benefit using graphene and other 2D materials could include targeted drug delivery systems to attack cancer cells while leaving other cells unharmed, remote electrical stimulation of nerves affected by neurodegenerative and other diseases, such as diabetes, plus smart dressings for burns and wounds.

As well as four major healthcare partners and two graphene SMEs, the 2D-Health project involves laboratories from across University spanning physics, chemistry, pharmacy and medicine.

Similarly, the University’s Nanomedicine Lab brings together bioengineering, pharmacology and nanotechnology and their translation to advanced, clinically-relevant therapeutics and diagnostics.